To assess AD neuropathological changes in our cohorts, we quantified the abundance of Aβ-42, total tau and phosphorylated tau (T231), a tau post-translation modification observed in neurofibrillary tangles (Fig. 1c,d). The gene discussed is MAPT; the disease is Alzheimer disease.